ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma. - Suzuki K; Otoyama Y; Matsumoto N; Masuo Y; Nakajima Y; Sugiura I; Fuji T; Nomura E; Ichikawa Y; Shimozuma Y; Uchikoshi M; Hayano M; et al. (Clinical pharmacokinetics, 2026)